Lexeo Therapeutics, Inc. (LXEO) ROE
- 2026-06-30: ROE -37.12%.
- 2026-03-31: ROE -37.80%.
- 2025-12-31: ROE -40.52%.
- 2025-09-30: ROE -86.87%.
Complete source-backed roe history.
- Available history
- 2022-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | -37.12% |
| 2026-03-31 | -37.80% |
| 2025-12-31 | -40.52% |
| 2025-09-30 | -86.87% |
| 2025-06-30 | -82.60% |
| 2025-03-31 | -124.05% |
| 2024-12-31 | -84.16% |
| 2024-09-30 | -62.15% |
| 2024-06-30 | -46.81% |
| 2024-03-31 | -37.94% |
| 2023-12-31 | -58.48% |
| 2023-09-30 | 41.02% |
| 2023-06-30 | 44.38% |
| 2023-03-31 | 49.88% |
| 2022-12-31 | 52.48% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -40.52% |
| 2024-12-31 | -84.16% |
| 2023-12-31 | -58.48% |
| 2022-12-31 | 52.48% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |